Rochester,NY 8/15/2009 12:48:34 AM
Teva Pharmaceutical Industries Ltd, TEVA - oxaliplatin injection has launched by Teva
Teva Pharmaceutical Industries Ltd
The official announcement of Teva Pharmaceutical Industries is that US Food and Drug Administration (FDA) approval and launch of oxaliplatin injection.
http://StockEinstein.com offers free daily stock alerts on companies ready to run. Sign up for our free alerts newsletter.
Teva's 505(b)(2) New Drug Application provides for the use of oxaliplatin injection, 50 mg/10 mL and 100 mg/20 mL for adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumour and treatment of advanced colorectal cancer.
StockEinstein.com has a dedicated team uncovering stocks ready to break and run. We apply time tested criteria and when one of these stocks meets or exceeds our benchmarks, our subscribers are immediately notified directly to their in-box.
This is a free service available only to our subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
During 2009 our alerts have resulted in an average price gain of 80%+.
Disclaimer: Full disclaimer at http://StockEinstein.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinstein, nor any of its affiliates are registered investment advisors or broker dealers.
